文献速递脑血管病外科神经重症

脑动静脉畸形出血的分子特征:一项系统综述

Molecular Signature of Brain Arteriovenous Malformation Hemorrhage: A Systematic Review.
PubMed 文献 · World Neurosurg · 2021-10-20

该研究遵循PRISMA指南系统检索多个数据库,最终纳入31篇文章分析脑动静脉畸形(bAVM)出血相关的分子特征。结果显示多种基因多态性通过增加炎症细胞因子(IL-6、IL-17A、IL-1β、TNF-α)、NOTCH通路、MMP-9和VEGF-α的表达而升高bAVM破裂风险。这些分子因素与细胞水平炎症增加及内皮改变导致血管壁不稳定相关。

要点

  • 多种基因多态性通过上调炎症因子、NOTCH通路、MMP-9和VEGF-α增加bAVM破裂风险。
  • 分子特征与细胞炎症及内皮改变所致血管壁不稳定相关。
  • 上述生物标志物有望用于个体化出血风险评估及未来治疗靶点。

核心结论

  • 多种分子因素与bAVM相关出血风险相关,涉及炎症增加和内皮改变导致的血管壁不稳定。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索Embase、Medline、Cochrane central、Scopus及中国知网、万方数据库。
  • 初检获3944篇文章,去重后余3108篇,经标题、摘要和全文筛选后最终纳入31篇进行分析。

主要发现

  • 鉴定出若干基因多态性通过增加某些炎症细胞因子(IL-6、IL-17A、IL-1β和TNF-α)、NOTCH通路、MMP-9和VEGF-α的表达而升高bAVM破裂风险。

临床怎么用

  • 上述分子因素可作为未来研究出血率的生物标志物,并可能成为基因治疗靶点。
  • 未来需进一步研究这些标志物与非侵入性诊断方法的关系,以改善患者个体化风险估计和治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The mechanisms of brain arteriovenous malformation (bAVM) development, formation, and progress are still poorly understood. By gaining more knowledge about the molecular signature of bAVM in relation to hemorrhage, we might be able to find biomarkers associated with this serious complication, which can function as a goal for further research and can be a potential target for gene therapy. AIMS: To provide a comprehensive overview of the molecular signature of bAVM-related hemorrhage We conducted a systematic review, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, of articles published in Embase, Medline, Cochrane central, Scopus, and Chinese databases (CNKI, Wanfang). SUMMARY OF REVIEW: Our search identified 3944 articles, of which 3108 remained after removal of duplicates. After title, abstract, and full-text screening, 31 articles were included for analysis. The results show an overview of molecular characteristics. Several genetic polymorphisms are identified that increase the risk of bAVM rupture by increasing the expression of certain inflammatory cytokines (interleukin [IL]-6, IL-17A, IL-1β, and tumor necrosis factor-α), NOTCH pathways, matrix metalloproteinase-9, and vascular endothelial growth factor-α. CONCLUSIONS: Several molecular factors are associated with the risk of bAVM-related hemorrhage. These factors are associated with increased inflammation on the cellular level and changes in the endothelium leading to instability of the vessel wall. Further investigation of these biomarkers regarding hemorrhage rates, together with their relationship with noninvasive diagnostic methods, should be a goal of future studies to improve the patient specific risk estimation and future treatment options.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Germans MR, Sun W, Sebök M, et al. Molecular Signature of Brain Arteriovenous Malformation Hemorrhage: A Systematic Review. World Neurosurg. 2021. PMID: 34687935. doi:10.1016/j.wneu.2021.10.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。